Advanced search
Publication Cover
Postgraduate Medicine Volume 134, 2022 - Issue 2
Submit an article Journal homepage
1,761
Views
5
CrossRef citations to date
0
Altmetric
Clinical focus: Cardiovascular disease- Original research

Patient preferences for mitral valve regurgitation treatment: a discrete choice experiment

Ellen Janssena ICON plc, Patient Centered Outcomes, Gaithersburg, MD, USAORCID Iconhttps://orcid.org/0000-0003-0405-4252
ORCID Icon,
Eric L. Keuffelb Health Finance & Access Initiative, Health Economics, Ardmore, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5350-2272
ORCID Icon,
Barry Lidenc Edwards Lifesciences, Patient Engagement, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0001-9228-8037
ORCID Icon,
Alissa Hannac Edwards Lifesciences, Patient Engagement, Irvine, CA, USAORCID Iconhttps://orcid.org/0000-0001-7246-2843
ORCID Icon &
John A. Rizzod Stony Brook University, State University of New York, Department of Family, Population and Preventive Medicine, Stony Brook, NY, USAORCID Iconhttps://orcid.org/0000-0002-0366-8503
ORCID Icon
Pages 125-142 | Received 19 Nov 2021, Accepted 16 Dec 2021, Published online: 11 Jan 2022

References

  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77(4):e25–e197.
  • Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011.
  • Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update: a report from the American heart association. Circulation. 2010;121(7):e46–e215.
  • Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–1365.
  • De Oliveira JF, Antunes MJ. Mitral valve repair: better than replacement. Heart. 2006;92(2):275–281.
  • Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol. 2018;71(1):25–36.
  • Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016;134(3):189–197. Circulation.
  • Hunter NL, O’Callaghan KM, Califf RM. Engaging patients across the spectrum of medical product development: view from the US food and drug administration. Jama. 2015;314(23):2499–2500.
  • Van Overbeeke E, Janssens R, Whichello C, et al. Design, conduct, and use of patient preference studies in the medical product life cycle: a multi-method study. Front Pharmacol. 2019;10:1395.
  • Oehrlein EM, Harris J, Balch A, et al. Improving access and quality of health care in the United States: shared goals among patient advocates. Patient-Patient-Centered Outcomes Res. 2021;14(5):687–690.
  • Hauber AB, González JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315.
  • Soekhai V, Whichello C, Levitan B, et al. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discov Today. 2019;24(7):1324–1331.
  • Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care. Vol. 11. Dordrecht, The Netherlands: Springer Science & Business Media; 2007.
  • Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13.
  • Soekhai V, de Bekker-grob EW, Ellis AR, et al. Discrete choice experiments in health economics: past, present and future. Pharmacoeconomics. 2019;37(2):201–226.
  • Fairchild AO, Katz EG, Reed SD, et al. Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: results from a clinical trial and panel. Neurol Psychiatry Brain Res. 2020;37:67–78.
  • Hollin IL, Peay H, Fischer R, et al. Engaging patients and caregivers in prioritizing symptoms impacting quality of life for duchenne and becker muscular dystrophy. Qual Life Res. 2018;27(9):2261–2273.
  • Janssen EM, Marshall DA, Hauber AB, et al. Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability? Expert Rev Pharmacoecon Outcomes Res. 2017;17(6):531–542.
  • Tervonen T, Schmidt-Ott T, Marsh K, et al. Assessing rationality in discrete choice experiments in health: an investigation into the use of dominance tests. Value Health. 2018;21(10):1192–1197.
  • Bridges JF, Tsai J-H, Janssen E, et al. How do members of the duchenne and becker muscular dystrophy community perceive a discrete-choice experiment incorporating uncertain treatment benefit? an application of research as an event. Patient-Patient-Centered Outcomes Res. 2019;12(2):247–257.
  • Swait J, Louviere J. The role of the scale parameter in the estimation and comparison of multinomial logit models. J Marketing Res. 1993;30(3):305–314.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.